CBC Group and Mubadala acquire UCB’s mature neurology and allergy business in China for US$680 million. New company is named NeuroGen Pharma, led by an experienced management team with a strong track ...
Apollo tried seven times to gain a foothold in the bidding but ultimately lost out to Skydance's $8 billion deal, an SEC ...
The question isn't whether middle management will change but how we can shape that change to create more effective, innovative and human-centric organizations.
Kevin Steinke, an analyst from Barrington, reiterated the Buy rating on Quad/Graphics (QUAD – Research Report). The associated price target ...
Meta's focus on user engagement and AI ads drives performance. Read why META stock offers great potential for tech portfolios ...
Wells Fargo analyst Zachary Fadem has maintained their bullish stance on SBUX stock, giving a Buy rating on November 21.Don't Miss our Black ...